| No. | Name | Structure | Gastrointestinal absorption | logKp (cm/s) | Bioavailability score |
| 1 | (6RS)-(2E,7E,9E)-6-Hydroxy-N-(2-hydroxy-2-methylpropyl)-11-oxo-2,7,9-dodecatrienamide | | High | −7.73 | 0.55 | 2 | (2E)-6,6-Dimethoxy-N-(2-hydroxy-2-methylpropyl)-2-hexenamide | | High | −7.50 | 0.55 | 3 | (2E,7E,9E)-N-(2-Hydroxy-2-methylpropyl)-11-ethoxy-6-hydroxy-dodeca-2,7,9-trienamide | | High | −7.41 | 0.55 | 4 | (2E,4E,8Z,11E)-2’-Hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide | | High | −7.41 | 0.55 | 5 | Tetradecatetraenamide | | High | −5.56 | 0.55 | 6 | N-[2-(3,4-Dimethoxyphenyl) ethyl]-3-phenyl-acrylamide | | High | −6.23 | 0.55 | 7 | Hydroxy-α-sanshool | | High | −5.90 | 0.55 | 8 | Hydroxy-γ-sanshool | | High | −5.61 | 0.55 | 9 | (2E,7E,9E)-N-(2-Hydroxy-2-methylpropyl)-6-ethoxy-11-hydroxy-dodeca-2,7,9-trienamide | | High | −7.41 | 0.55 | 10 | Arnothianamide | | High | −5.66 | 0.55 | 11 | (11RS)-(2E,7E,9E)-11-hyHydroxydroxy-N-(2-hydroxy-2-methylpropyl)-6-oxo-2,7,9-dodecatrienamide | | High | −7.78 | 0.55 | 12 | (2E,6E,8E)-N-(2-Hydroxy-2-methylpropyl)-10-hydroxy-5-oxo-undeca-2,6,8-trienamide | | High | −7.90 | 0.55 | 13 | (2E,4E,9E,11E)-N-(2-hydroxy-2-methypropyl)-8-hydroxy-13-oxo-2,4,9,11-tetradecatetraenamide | | High | −7.44 | 0.55 | 14 | (6RS,11RS)-(2E,7E,9E)-N-(2-Hydroxy-2-methylpropyl)-6,11-dioxo-2,7,9-dodecatrienamide | | High | −7.71 | 0.55 | 15 | γ-Sanshool | | High | −4.52 | 0.55 | 16 | Rutin | | High | −7.05 | 0.55 | 17 | Hydroxy-β-sanshool | | High | −5.90 | 0.55 | 18 | (2E,4E,8Z,11Z)-N-(2-Hydroxy-2-methylpropyl)-2,4,8,11-tetradecatetraenamide | | High | −5.56 | 0.55 | 19 | 3,5,6-Trihydroxy-7,4´-dimethoxy flavone | | High | −6.31 | 0.55 | 20 | β-Sanshool | | High | −4.82 | 0.55 |
|
|